SCHEMBL25914665

SCHEMBL25914665

Cn1c(NCCF)ncc(-c2ccc3cc(Oc4ccnc(Br)c4)ccc3n2)c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 3/20 0.39
▸ PDGFRB P09619 2/20 0.39
▸ LCK P06239 2/20 0.39
▸ PDGFRA P16234 2/20 0.39
▸ FLT3 P36888 2/20 0.39
▸ KIT P10721 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ PTK6 Q13882 1/20 0.39
▸ CYP3A4 P08684 5/20 0.35
▸ SCN9A Q15858 2/20 0.33
▸ BRAF P15056 4/20 0.33
▸ RAF1 P04049 3/20 0.33
▸ MAPT P10636 2/20 0.33
▸ AURKA O14965 1/20 0.32
▸ RPS6KA5 O75582 1/20 0.32
▸ MET P08581 1/20 0.32
▸ PIM1 P11309 1/20 0.32
▸ HGF P14210 1/20 0.32
▸ RPS6KB1 P23443 1/20 0.32
▸ KDR P35968 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25914667 0.86 BRAF (0.44) CSF1RPDGFRBLCKPDGFRAFLT3
SCHEMBL25911790 0.86 CSF1R (0.53) CSF1RPDGFRBLCKPDGFRAFLT3
SCHEMBL25914529 0.86 GAA (0.41) CSF1RPDGFRBLCKPDGFRAFLT3
SCHEMBL25912706 0.83 CSF1R (0.43) CSF1RPDGFRBLCKPDGFRAFLT3
SCHEMBL25913399 0.82 CSF1R (0.39) CSF1RPDGFRBLCKPDGFRAFLT3
SCHEMBL25914740 0.82 CSF1R (0.35) CSF1RPDGFRBLCKPDGFRAFLT3
SCHEMBL25912704 0.80 CSF1R (0.39) CSF1RPDGFRBLCKPDGFRAFLT3
SCHEMBL25910288 0.80 CSF1R (0.41) CSF1RPDGFRBLCKPDGFRAFLT3
SCHEMBL25914664 0.80 ESR1 (0.38) CSF1RPDGFRBLCKPDGFRAFLT3
SCHEMBL25914852 0.79 CSF1R (0.40) CSF1RPDGFRBLCKPDGFRAFLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback